Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice.
about
A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infectionsA review of nanotechnological approaches for the prophylaxis of HIV/AIDS.Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculationVaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunityCarnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen.Immunoglobulin A antibodies against internal HIV-1 proteins neutralize HIV-1 replication inside epithelial cellsInduction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120.Intranasal delivery of vaccines against HIV.Nanoparticles as protein and gene carriers to mucosal surfaces.Concanavalin A-conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal drug delivery to the cervical lymph nodes.Multifunctional conjugation of proteins on/into bio-nanoparticles prepared by amphiphilic poly(gamma-glutamic acid).IgG responses to intranasal immunization with cholera-toxin-immobilized polymeric nanospheres in mice.
P2860
Q30369008-2CED53D0-5F29-400A-90BD-72979D4B8DBBQ30431343-3F980DE0-C349-42DB-AF9D-79996126B2EFQ33611645-2257A0D6-D11C-43A5-A03F-D9F540D4D84FQ33788701-C3BDCEB4-10E7-4542-8CFD-D35AD77B2445Q34415303-369C2C82-C195-4EEF-AC0D-9CBBB1B9AB77Q34993838-20D7E0F3-E8AE-4811-BA11-0A4F9FB840F5Q35636425-2E0278EE-4523-4CF3-A5A6-B95280542A7DQ36098933-03954E55-7EFD-4230-B038-0D792F79AD78Q36409054-2845F64C-EBAF-4A06-B501-0C80529D6864Q37331802-D8AE34FA-E895-4F0E-90B3-A815EE01627BQ39158263-7AAC1DA7-FB6A-4958-A765-3E45830A957BQ51123426-ECA278BA-02E6-441D-99B0-8A66E4187B1BQ51643667-C48777A4-6848-4DFE-8FDD-3231A4454ECB
P2860
Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Mucosal immunization with inac ...... nal antibody response in mice.
@en
Mucosal immunization with inac ...... nal antibody response in mice.
@nl
type
label
Mucosal immunization with inac ...... nal antibody response in mice.
@en
Mucosal immunization with inac ...... nal antibody response in mice.
@nl
prefLabel
Mucosal immunization with inac ...... nal antibody response in mice.
@en
Mucosal immunization with inac ...... nal antibody response in mice.
@nl
P2093
P2860
P356
P1476
Mucosal immunization with inac ...... inal antibody response in mice
@en
P2093
Katsuya Hiraishi
Masakazu Adachi
Masaki Kawamura
Masamichi Ueno
Masanori Baba
Mitsuru Akashi
Takami Akagi
P2860
P304
P356
10.1002/JMV.10279
P577
2003-02-01T00:00:00Z